Hsiri Therapeutics
Bill has been in the pharmaceutical industry for over twenty-five years, initially at Searle and then at SmithKline Beecham. In the latter company, he held various positions and eventually was Senior-Vice President and Director of Worldwide Clinical Research. Bill was also the President, and CEO of Phoenix Data Systems before selling the company in 2008.
This person is not in any offices
Hsiri Therapeutics
Hsiri Therapeutics, a private biopharmaceutical company, is dedicated to the discovery and development of novel antibiotics to treat multi-drug resistant (MDR) infections, with a specific focus on gram-negative bacteria and mycobacterial diseases.